Of particular interest was to elucidate whether therapeutic intervention, by blocking highly expressed inhibitory pathways like TIM-3 with monoclonal antibodies, has an immunomodulatory effect during infection and whether this can influence the persistence and thus the development of CD. This evidence concerns the gene HAVCR2 and infection.